<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-INR-17010805</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-03-06</date_registration>
      <primary_sponsor>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</primary_sponsor>
      <public_title>The clinical research of security and validity for applying enriched bone marrow stem cells rapidly recombinating parous biomaterial to multi-segment lumber intervertebral fusion</public_title>
      <acronym />
      <scientific_title>The clinical research of security and validity for applying enriched bone marrow stem cells rapidly recombinating parous biomaterial to multi-segment lumber intervertebral fusion</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-03-01</date_enrolment>
      <type_enrolment />
      <target_size>treatment group:96;controlled group:96;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=18386</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>lumber spine degeneration disease and lumbar vertebral fracture</hc_freetext>
      <i_freetext>treatment group:using enriched bone marrow stem cells recombinating parous biomaterial for implantation;controlled group:autologous bone transplantation;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Xin Wang</firstname>
        <middlename />
        <lastname />
        <address>639 Zhizaoju Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15921963129</telephone>
        <email>walsheim@163.com</email>
        <affiliation>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Jie Zhao</firstname>
        <middlename />
        <lastname />
        <address>639 Zhizaoju Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15921963129</telephone>
        <email>prof_zhao@189.cn</email>
        <affiliation>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>(1) Aged from 18 to 65 years, male and female;
(2) Two or three segmental lumber spine disease requiring decompression surgery and intervertebral fusion;
(3) No admission for other clinical study in recent three months;
(4) No acute infection,mental disorder and calcification metabolic disorders;
(5) Be willing to sign the informed consent.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>65</agemax>
      <gender>Both</gender>
      <exclusion_criteria>(1) pathological fracture caused by osteopathy such as benign or malignant tumor;
(2) acute or severe infection or chronic infection in its active phase;
(3) osteoporosis,lacking critical bone in fracture site or comminuted fracture;
(4) metabolic disorders,immune dysfunction or drug abuse;
(5) accompanied of cardiac,lung,liver,kidney,hemopoietic system or endocrine system disease;
(6) be allergic to implants or various medicine;
(7) pregnant woman or lactating women;
(8) patients unwilling or cannot limit activities or follow medical advice;
(9) too weak to evaluate the security and validity of implants.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>fusion rate;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>JOA score;intervertebral space height;enrichment rate of stem cells;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Newly-developed technique joint  project of SHDC</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>1990-01-01</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>